Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

Report of the Japanese Pharmacopoeia 130th Anniversary Symposium - Challenges for the future -

Outline of the Japanese Pharmacopoeia 130th Anniversary Symposium

Date: September 15, 2016
Venue: Nadao Hall (Tokyo, Kasumigaseki)
Organizer:
Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA)
Co-Organizers:
Federation of Pharmaceutical Manufacturers' Association of Japan (FPMAJ) and Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)
 

Presentation Slides

See program for details
 

Part 1: Japanese Pharmacopoeia 130th Anniversary Ceremony

Moderator: Dr. Seiko Miyazaki (PMDA)

Title Speaker
Address Director-General, Pharmaceutical and Environmental Health Bureau, MHLW
Mr. Toshihiko Takeda
Salute from the Organizer Chief Executive, PMDA
Dr. Tatsuya Kondo
Congratulations President, PAFSC & Chairman, JP Committee
Dr. Mitsuru Hashida
Congratulations President, FPMAJ
Mr. Masayo Tada
Congratulations President, PSJ
Dr. Shigeru Ohta
 

Part 2: Japanese Pharmacopoeia 130th Anniversary Symposium

Moderator for Session 1: Dr. Seiko Miyazaki (PMDA)
Moderator for Sessions 2 and after: Dr. Mayumi Shikano (PMDA)

Title Speaker
Keynote Address
"Advances in Pharmaceutical Regulations in Japan and the Path of the Japanese Pharmacopoeia"
Councilor for Pharmaceutical Affairs, MHLW
Mr. Kazuhiko Mori
Session 1
Expectation for the future and the role of the JP
Director-General, NIHS
Dr. Toru Kawanishi
 
Chairman, Pharmacopoeial Committee, FPMAJ
Mr. Tomomi Kawamata
 
President, Japan Self-Medication Industry
Dr. Tatsuo Kurokawa
 
Senior Managing Director, PMRJ
Mr. Shigeki Tsuda
Session 2
Latest trends and future efforts of each world Pharmacopoeia in the progress of globalization
Director, European Directorate for the Quality of Medicines & HealthCare, Council of Europe
Dr. Susanne Keitel
 
Chief Science Officer and Chair, Council of Experts, United States Pharmacopeia
Dr. Jaap Venema
 
Deputy Director of Comprehensive Division, Chinese Pharmacopoeia Commission
Dr. Zonghua Song
 
Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission
Dr. G.N. Singh
 
Regulation and Health Surveillance Expert, Head of Brazilian Farmacopoeia Coordination
Mr. Varley Dias Sousa
 
Office Director, Office of Standards and Guidelines Development, PMDA
Dr. Seiko Miyazaki
Session 3
Outcome of the 7th International Meeting of World Pharmacopoeias and its Future Prospects
Group Lead, Medicines Quality Assurance, World Health Organization
Dr. Sabine Kopp
Roundtable Discussion
Vision for the future of the Pharmacopoeia and international harmonization of pharmacopoeia
Facilitator: Dr. Toru Kawanishi
Panelist: All the Speakers of Session2 and 3

Director, Division of Pharmacopoeia and Standards for Drugs, Office of Standards and
Guidelines Development, PMDA,
Dr. Naoyuki Yabana
Closing remarks Director, Pharmaceutical Evaluation Division,
Pharmaceutical and Environmental Health Bureau, MHLW

Mr. Masanobu Yamada